| Is Abnormal 50g-Glucose Challenge Testing an Independent Predictor of Adverse Pregnancy Outcome? | |
| | |
MedLine Citation:
|
PMID: 22881605 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract OBJECTIVE: To determine whether an abnormal 50g-glucose challenge test (GCT) is independently associated with adverse pregnancy outcome. METHODS: A retrospective study of women with abnormal GCT (>140 mg/dl) but normal subsequent 100g-oral glucose tolerance test (OGTT). Pregnancy outcome was compared with that of women with normal GCT (<140 mg/dl). RESULTS: Of the 79,153 women delivered during the study period, the results of the GCT were available for 14,268. Of these, 809 (5.7%) had an abnormal GCT and normal OGTT and were eligible for the study group. An abnormal GCT was independently associated with an increased risk for macrosomia (OR=2.0, 95%-CI 1.5-2.7), LGA (OR=1.6, 95%-CI 1.3-2.0), cesarean section (OR=1.3, 95%-CI 1.1-1.6), respiratory morbidity (OR=1.6, 95%-CI 1.1-2.7) and neonatal hypoglycemia (OR=1.8, 95%-CI 1.1-3.2). In contrast, an abnormal GCT was associated with decreased risk for preterm delivery at less than 37 weeks (OR=0.7, 95%-CI 0.5-0.9) and 34 weeks (OR=0.3, 95%-CI 0.1-0.6). The association between abnormal GCT and adverse pregnancy outcome was unrelated to the degree of GCT abnormality except for cases in which the GCT was extremely high (>=180 mg/dl). CONCLUSION: Women with abnormal GCT result are at increased risk for adverse pregnancy outcome even in the presence of a normal subsequent OGTT. |
| | |
Authors:
|
Nir Melamed; Liran Hiersch; Moshe Hod; Rony Chen; Arnon Wiznitzer; Yariv Yogev |
Related Documents
:
|
22324495 - Do hypertensive diseases of pregnancy disrupt neurocognitive development in offspring? 22854275 - Midbrain and falx in fetuses with absent corpus callosum at 11-13 weeks. 21984575 - Do assisted conception twins have an increased risk for anencephaly? 19357505 - Efficacy and safety of the long-term administration of low-molecular-weight heparins in... 9793975 - Hyperglycosylated hcg, a potential alternative to hcg in down syndrome screening. 21134505 - A pilot study on the use of letrozole with either misoprostol or mifepristone for termi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-8-13 |
Journal Detail:
|
Title: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians Volume: - ISSN: 1476-4954 ISO Abbreviation: J. Matern. Fetal. Neonatal. Med. Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-8-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101136916 Medline TA: J Matern Fetal Neonatal Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activ...
Next Document: Depletion of deep marine food patches forces divers to give up early.